Related references
Note: Only part of the references are listed.RTS,S/AS01 vaccine (Mosquirix?): an overview
Matthew B. Laurens
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)
Live and Let Dye: Visualizing the Cellular Compartments of the Malaria Parasite Plasmodium falciparum
Marleen Linzke et al.
CYTOMETRY PART A (2020)
Chagas Disease Infection Prevalence and Vector Exposure in a High-Risk Population of Texas Hunters
Sarah M. Gunter et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2020)
Marine Pharmacology in 2014-2015: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti -Inflammatory, Antiprotozoal, Antituberculosis, Antiviral, and Anthelmintic Activities; Affecting the Immune and Nervous Systems, and Other Miscellaneous Mechanisms of Action
Alejandro M. S. Mayer et al.
MARINE DRUGS (2020)
Current trends in the pharmacological management of Chagas disease
Vanessa Ribeiro et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2020)
Pharmacokinetics, Safety, and Efficacy of an Allometric Miltefosine Regimen for the Treatment of Visceral Leishmaniasis in Eastern African Children: An Open-label, Phase II Clinical Trial
Jane Mbui et al.
CLINICAL INFECTIOUS DISEASES (2019)
Walking a tightrope: drug discovery in visceral leishmaniasis
Rafael Balana-Fouce et al.
DRUG DISCOVERY TODAY (2019)
Human African Trypanosomiasis Progress and Stagnation
Emmanuel Bottieau et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2019)
American Trypanosomiasis (Chagas Disease)
Luis E. Echeverria et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2019)
Updating the modified Thompson test by using whole-body bioluminescence imaging to replace traditional efficacy testing in experimental models of murine malaria
Diana Caridha et al.
MALARIA JOURNAL (2019)
The past, present and future of anti-malarial medicines
Edwin G. Tse et al.
MALARIA JOURNAL (2019)
Spiralyde A, an Antikinetoplastid Dolabellane from the Brown Alga Dictyota spiralis
Olfa Chiboub et al.
MARINE DRUGS (2019)
A chronic bioluminescent model of experimental visceral leishmaniasis for accelerating drug discovery
Raquel Alvarez-Velilla et al.
PLOS NEGLECTED TROPICAL DISEASES (2019)
Accelerating Drug Discovery Efforts for Trypanosomatidic Infections Using an Integrated Transnational Academic Drug Discovery Platform
Carolina B. Moraes et al.
SLAS DISCOVERY (2019)
The 2017 Oslo conference report on neglected tropical diseases and emerging/re-emerging infectious diseases - focus on populations underserved
Katharina Klohe et al.
INFECTIOUS DISEASES OF POVERTY (2019)
Marine-Derived Anticancer Agents: Clinical Benefits, Innovative Mechanisms, and New Targets
Renato B. Pereira et al.
MARINE DRUGS (2019)
Route map for the discovery and pre-clinical development of new drugs and treatments for cutaneous leishmaniasis
Diana Caridha et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2019)
An evaluation of benznidazole as a Chagas disease therapeutic
Ivo S. Caldas et al.
EXPERT OPINION ON PHARMACOTHERAPY (2019)
Targeting pteridine reductase 1 and dihydrofolate reductase: the old is a new trend for leishmaniasis drug discovery
Gustavo Machado das Neves et al.
FUTURE MEDICINAL CHEMISTRY (2019)
Malaria eradication within a generation: ambitious, achievable, and necessary
Richard G. A. Feachem et al.
LANCET (2019)
Current and promising novel drug candidates against visceral leishmaniasis
Rosa M. Reguera et al.
PURE AND APPLIED CHEMISTRY (2019)
Validation of the protein kinase PfCLK3 as a multistage cross-species malarial drug target
Mahmood M. Alam et al.
SCIENCE (2019)
Drug discovery for chagas disease: A viewpoint
Jadel Muller Kratz
ACTA TROPICA (2019)
Antiprotozoal activities of marine polyether triterpenoids
Ana R. Diaz-Marrero et al.
BIOORGANIC CHEMISTRY (2019)
Identification of Antimalarial Inhibitors Using Late-Stage Gametocytes in a Phenotypic Live/Dead Assay
Timothy P. Spicer et al.
SLAS DISCOVERY (2019)
An overview of leishmanization experience: A successful control measure and a tool to evaluate candidate vaccines
Mehdi Mohebali et al.
ACTA TROPICA (2019)
Natural Product Repertoire of the Genus Amphimedon
Nourhan Hisham Shady et al.
MARINE DRUGS (2019)
Evaluating drug resistance in visceral leishmaniasis: the challenges
S. Hendrickx et al.
PARASITOLOGY (2018)
Chemotherapeutics of visceral leishmaniasis: present and future developments
Shyam Sundar et al.
PARASITOLOGY (2018)
NCI Program for Natural Product Discovery: A Publicly-Accessible Library of Natural Product Fractions for High-Throughput Screening
Christopher C. Thornburg et al.
ACS CHEMICAL BIOLOGY (2018)
Molecular insights into trypanothione reductase-inhibitor interaction: A structure-based review
Neha Tiwari et al.
ARCHIV DER PHARMAZIE (2018)
The antimalarial pipeline
Rob Hooft van Huijsduijnen et al.
CURRENT OPINION IN PHARMACOLOGY (2018)
Drugs in Development for Malaria
Elizabeth A. Ashley et al.
DRUGS (2018)
Chagas disease in Europe: A long way to go
Spinello Antinori et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2018)
Plasmodium falciparum dihydroorotate dehydrogenase: a drug target against malaria
Lucas V. B. Hoelz et al.
FUTURE MEDICINAL CHEMISTRY (2018)
A new chimeric triple reporter fusion protein as a tool for in vitro and in vivo multimodal imaging to monitor the development of African trypanosomes and Leishmania parasites
Estefania Calvo-Alvarez et al.
INFECTION GENETICS AND EVOLUTION (2018)
Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial
Victor Kande Betu Ku Mesu et al.
LANCET (2018)
Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study
Alejandro Llanos-Cuentas et al.
LANCET INFECTIOUS DISEASES (2018)
Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial
Faustino Torrico et al.
LANCET INFECTIOUS DISEASES (2018)
Efficacy and safety of artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Sudan: a systematic review and meta-analysis
Ishag Adam et al.
MALARIA JOURNAL (2018)
Unclear association between levels of Plasmodium falciparum lactate dehydrogenase (PfLDH) in saliva of malaria patients and blood parasitaemia: diagnostic implications?
Eva A. Nambati et al.
MALARIA JOURNAL (2018)
Multistage inhibitors of the malaria parasite: Emerging hope for chemoprotection and malaria eradication
Poonam et al.
MEDICINAL RESEARCH REVIEWS (2018)
Fexinidazole: A New Drug for African Sleeping Sickness on the Horizon
Michael P. Pollastri
TRENDS IN PARASITOLOGY (2018)
Melarsoprol Resistance in African Trypanosomiasis
Alan H. Fairlamb et al.
TRENDS IN PARASITOLOGY (2018)
A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum
Alison Roth et al.
NATURE COMMUNICATIONS (2018)
Functional screening of selective mitochondrial inhibitors of Plasmodium
Maria G. Gomez-Lorenzo et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2018)
Fragment-Based Screening of a Natural Product Library against 62 Potential Malaria Drug Targets Employing Native Mass Spectrometry
Hoan Vu et al.
ACS INFECTIOUS DISEASES (2018)
Recent Development of Visceral Leishmaniasis Treatments: Successes, Pitfalls, and Perspectives
Fabiana Alves et al.
CLINICAL MICROBIOLOGY REVIEWS (2018)
Current Screening Methodologies in Drug Discovery for Selected Human Diseases
Olga Maria Lage et al.
MARINE DRUGS (2018)
Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis
Susan Wyllie et al.
NATURE (2018)
Antimalarial Transmission-Blocking Interventions: Past, Present, and Future
M. J. Delves et al.
TRENDS IN PARASITOLOGY (2018)
The Long Wait for a New Drug for Human African Trypanosomiasis
Catriona H. Baker et al.
TRENDS IN PARASITOLOGY (2018)
A high throughput screen for next-generation leads targeting malaria parasite transmission
Michael J. Delves et al.
NATURE COMMUNICATIONS (2018)
Clinical and pharmacological profile of benznidazole for treatment of Chagas disease
Jadel Mueller Kratz et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2018)
Target Validation and Identification of Novel Boronate Inhibitors of the Plasmodium falciparum Proteasome
Stanley C. Xie et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Open-source discovery of chemical leads for next-generation chemoprotective antimalarials
Yevgeniya Antonova-Koch et al.
SCIENCE (2018)
Monitoring the elimination of human African trypanosomiasis: Update to 2016
Jose R. Franco et al.
PLOS NEGLECTED TROPICAL DISEASES (2018)
Tafenoquine for travelers′ malaria: evidence, rationale and recommendations
J. Kevin Baird
JOURNAL OF TRAVEL MEDICINE (2018)
Long-term Clinical Outcomes in Visceral Leishmaniasis/Human Immunodeficiency Virus-Coinfected Patients During and After Pentamidine Secondary Prophylaxis in Ethiopia: A Single-Arm Clinical Trial
Ermias Diro et al.
CLINICAL INFECTIOUS DISEASES (2018)
Evaluation of Parameters Impacting Drug Susceptibility in Intracellular Trypanosoma cruzi Assay Protocols
Gyongseon Yang et al.
SLAS DISCOVERY (2017)
Antileishmanial activity of meroditerpenoids from the macroalgae Cystoseira baccata
Carolina Bruno de Sousa et al.
EXPERIMENTAL PARASITOLOGY (2017)
Cheminformatic Analysis of Antimalarial Chemical Space Illuminates Therapeutic Mechanisms and Offers Strategies for Therapy Development
Julia Nogueira Varela et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2017)
The care and feeding of a commercial liposomal product: liposomal amphotericin B (AmBisome®)
Gerard M. Jensen
JOURNAL OF LIPOSOME RESEARCH (2017)
Human African trypanosomiasis
Philippe Buscher et al.
LANCET (2017)
Neglected tropical diseases: progress towards addressing the chronic pandemic
David H. Molyneux et al.
LANCET (2017)
Novel lead structures with both Plasmodium falciparum gametocytocidal and asexual blood stage activity identified from high throughput compound screening
Wei Sun et al.
MALARIA JOURNAL (2017)
Marine Algae as Source of Novel Antileishmanial Drugs: A Review
Lauve Rachel Tchokouaha Yamthe et al.
MARINE DRUGS (2017)
Trypanothione Reductase: A Target for the Development of Anti-Trypanosoma cruzi Drugs
Karina Vazquez et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2017)
Opportunities and challenges in phenotypic drug discovery: an industry perspective
John G. Moffat et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need
Mark C. Field et al.
NATURE REVIEWS MICROBIOLOGY (2017)
Expression profiling of Sudanese visceral leishmaniasis patients pre- and post-treatment with sodium stibogluconate
M. A. M. Salih et al.
PARASITE IMMUNOLOGY (2017)
Adaptation and optimization of a fluorescence-based assay for in vivo antimalarial drug screening
Maria H. Arias et al.
PARASITOLOGY RESEARCH (2017)
Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh
Ridwanur Rahman et al.
PLOS NEGLECTED TROPICAL DISEASES (2017)
Development in Assay Methods for in Vitro Antimalarial Drug Efficacy Testing: A Systematic Review
Shweta Sinha et al.
FRONTIERS IN PHARMACOLOGY (2017)
Experimental and Clinical Treatment of Chagas Disease: A Review
Policarpo Ademar Sales Junior et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2017)
Parasite Polyamines as Pharmaceutical Targets
Sigrid Roberts et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
Leishmaniasis drug discovery: recent progress and challenges in assay development
Bilal Zulfigar et al.
DRUG DISCOVERY TODAY (2017)
Prevention of congenital Chagas disease by Benznidazole treatment in reproductive-age women. An observational study
Maria G. Alvarez et al.
ACTA TROPICA (2017)
Neglected Tropical Diseases: Epidemiology and Global Burden
Amal K. Mitra et al.
TROPICAL MEDICINE AND INFECTIOUS DISEASE (2017)
Challenges in the management of Chagas disease in Latin-American migrants in Europe
B. Monge-Maillo et al.
CLINICAL MICROBIOLOGY AND INFECTION (2017)
Pharmacokinetics of Benznidazole in Healthy Volunteers and Implications in Future Clinical Trials
I. Molina et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Brentuximab Vedotin: A Review in CD30-Positive Hodgkin Lymphoma
Lesley J. Scott
DRUGS (2017)
Novel Very Long-Chain α-Methoxylated Δ5,9 Fatty Acids from the Sponge Asteropus niger Are Effective Inhibitors of Topoisomerases IB
Nestor M. Carballeira et al.
LIPIDS (2016)
Strategies for the Optimization of Natural Leads to Anticancer Drugs or Drug Candidates
Zhiyan Xiao et al.
MEDICINAL RESEARCH REVIEWS (2016)
Current drug therapy and pharmaceutical challenges for Chagas disease
Jose Bermudez et al.
ACTA TROPICA (2016)
Assessment of the Worldwide Antimalarial Resistance Network Standardized Procedure for In Vitro Malaria Drug Sensitivity Testing Using SYBR Green Assay for Field Samples with Various Initial Parasitemia Levels
Agnes C. Cheruiyot et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Luciferase-Based, High-Throughput Assay for Screening and Profiling Transmission-Blocking Compounds against Plasmodium falciparum Gametocytes
Leonardo Lucantoni et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Antileishmanial Mechanism of Diamidines Involves Targeting Kinetoplasts
Gyongseon Yang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Marine-Derived Pharmaceuticals - Challenges and Opportunities
Ulrike Lindequist
BIOMOLECULES & THERAPEUTICS (2016)
Marine Sponges as a Drug Treasure
Komal Anjum et al.
BIOMOLECULES & THERAPEUTICS (2016)
African sleeping sickness
Lucy Hedley et al.
BRITISH JOURNAL OF HOSPITAL MEDICINE (2016)
High-Throughput Assay and Discovery of Small Molecules that Interrupt Malaria Transmission
David M. Plouffe et al.
CELL HOST & MICROBE (2016)
Liposomal Amphotericin B (AmBisome®): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions
Neil R. H. Stone et al.
DRUGS (2016)
Review on the clinical use of eribulin mesylate for the treatment of breast cancer
Olexiy Aseyev et al.
EXPERT OPINION ON PHARMACOTHERAPY (2016)
The RTS,S/AS01 malaria vaccine in children 5 to 17 months of age at first vaccination
Pascale Vandoolaeghe et al.
EXPERT REVIEW OF VACCINES (2016)
A chemical susceptibility profile of the Plasmodium falciparum transmission stages by complementary cell-based gametocyte assays
Sarah D'Alessandro et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial
George D. Demetri et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Repositioning Antitubercular 6-Nitro-2,3-dihydroimidazo[2,1-b][1,3]oxazoles for Neglected Tropical Diseases: Structure-Activity Studies on a Preclinical Candidate for Visceral Leishmaniasis
Andrew M. Thompson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015
Nicholas J. Kassebaum et al.
LANCET (2016)
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial
Patrick Schoffski et al.
LANCET (2016)
Global burden on neglected tropical diseases
Men-Bao Qian et al.
LANCET INFECTIOUS DISEASES (2016)
Elimination of visceral leishmaniasis on the Indian subcontinent
Om Prakash Singh et al.
LANCET INFECTIOUS DISEASES (2016)
The Brown Alga Stypopodium zonale (Dictyotaceae): A Potential Source of Anti-Leishmania Drugs
Deivid Costa Soares et al.
MARINE DRUGS (2016)
Marine natural products
John W. Blunt et al.
NATURAL PRODUCT REPORTS (2016)
Phenoyoic Screens in Antimalarial Druc Discovery
Marisa L. Hovlid et al.
TRENDS IN PARASITOLOGY (2016)
Current status on prevention and treatment of canine leishmaniasis
Rosa M. Reguera et al.
VETERINARY PARASITOLOGY (2016)
Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date
Yehenew A. Ebstie et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2016)
Primaquine treatment and relapse in Plasmodium vivax malaria
Kumar Rishikesh et al.
PATHOGENS AND GLOBAL HEALTH (2016)
Pentamidine Is Not a Permeant but a Nanomolar Inhibitor of the Trypanosoma brucei Aquaglyceroporin-2
Jie Song et al.
PLOS PATHOGENS (2016)
High-Throughput Luciferase-Based Assay for the Discovery of Therapeutics That Prevent Malaria
Justine Swann et al.
ACS INFECTIOUS DISEASES (2016)
Role of Cytochrome P450 2C8 in Drug Metabolism and Interactions
Janne T. Backman et al.
PHARMACOLOGICAL REVIEWS (2016)
Yeast-Based High-Throughput Screen Identifies Plasmodium falciparum Equilibrative Nucleoside Transporter 1 Inhibitors That Kill Malaria Parasites
I. J. Frame et al.
ACS CHEMICAL BIOLOGY (2015)
Imaging-Based High-Throughput Screening Assay To Identify New Molecules with Transmission-Blocking Potential against Plasmodium falciparum Female Gamete Formation
Celia Miguel-Blanco et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
High-Content Assay for Measuring Intracellular Growth of Leishmania in Human Macrophages
Michael J. Dagley et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2015)
Development of Small-Molecule Trypanosoma brucei N-Myristoyltransferase Inhibitors: Discovery and Optimisation of a Novel Binding Mode
Daniel Spinks et al.
CHEMMEDCHEM (2015)
Trypanosomatids see the light: recent advances in bioimaging research
Estefania Calvo-Alvarez et al.
DRUG DISCOVERY TODAY (2015)
Manzamine alkaloids as antileishmanial agents: A review
Penta Ashok et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Cutaneous and mucocutaneous leishmaniasis Clinical perspectives
Marc Z. Handler et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
Arsenic, antimony, and Leishmania: has arsenic contamination of drinking water in India led to treatment- resistant kala-azar?
Meghan Perry et al.
LANCET (2015)
Congenital Chagas disease: an update
Yves Carlier et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2015)
Anti-Protozoal Activities of Cembrane-Type Diterpenes from Vietnamese Soft Corals
Nguyen Phuong Thao et al.
MOLECULES (2015)
Hit and lead criteria in drug discovery for infectious diseases of the developing world
Kei Katsuno et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Chagas' Disease
Caryn Bern
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Antileishmanial activity of fucosterol recovered from Lessonia vadosa Searles (Lessoniaceae) by SFE, PSE and CPC
Monica Becerra et al.
PHYTOCHEMISTRY LETTERS (2015)
The discovery of artemisinin and the Nobel Prize in Physiology or Medicine
Su Xin-Zhuan et al.
SCIENCE CHINA-LIFE SCIENCES (2015)
A simple and predictive phenotypic High Content Imaging assay for Plasmodium falciparum mature gametocytes to identify malaria transmission blocking compounds
Leonardo Lucantoni et al.
SCIENTIFIC REPORTS (2015)
New Compound Sets Identified from High Throughput Phenotypic Screening Against Three Kinetoplastid Parasites: An Open Resource
Imanol Pena et al.
SCIENTIFIC REPORTS (2015)
Killing the hypnozoite - drug discovery approaches to prevent relapse in Plasmodium vivax
Brice Campo et al.
PATHOGENS AND GLOBAL HEALTH (2015)
Effectiveness Study of Paromomycin IM Injection (PMIM) for the Treatment of Visceral Leishmaniasis (VL) in Bangladesh
Kazi M. Jamil et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
Infrared Fluorescent Imaging as a Potent Tool for In Vitro, Ex Vivo and In Vivo Models of Visceral Leishmaniasis
Estefania Calvo-Alvarez et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
Chimerization at the AQP2-AQP3 locus is the genetic basis of melarsoprol-pentamidine cross-resistance in clinical Trypanosoma brucei gambiense isolates
Fabrice E. Graf et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2015)
Biodiversity, Anti-Trypanosomal Activity Screening, and Metabolomic Profiling of Actinomycetes Isolated from Mediterranean Sponges
Cheng Cheng et al.
PLOS ONE (2015)
Chagas disease and transfusion medicine: a perspective from non-endemic countries
Andrea Angheben et al.
BLOOD TRANSFUSION (2015)
High-Throughput Screening Platform for Natural Product-Based Drug Discovery Against 3 Neglected Tropical Diseases: Human African Trypanosomiasis, Leishmaniasis, and Chagas Disease
F. Annang et al.
JOURNAL OF BIOMOLECULAR SCREENING (2015)
Chagas Disease Drug Discovery: Toward a New Era
Eric Chatelain
JOURNAL OF BIOMOLECULAR SCREENING (2015)
Development of an Ex Vivo Lymph Node Explant Model for Identification of Novel Molecules Active against Leishmania major
Alex G. Peniche et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
2-Octadecynoic acid as a dual life stage inhibitor of Plasmodium infections and plasmodial FAS-II enzymes
Nestor M. Carballeira et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Recent Approaches to Chemical Discovery and Development Against Malaria and the Neglected Tropical Diseases Human African Trypanosomiasis and Schistosomiasis
Mathew Njoroge et al.
CHEMICAL REVIEWS (2014)
Introduction: Drug Discovery and Development for Neglected Diseases
Louise S. Goupil et al.
CHEMICAL REVIEWS (2014)
Manzamine alkalodis: isolation, cytotoxicity, antimalarial activity and SAR studies
Penta Ashok et al.
DRUG DISCOVERY TODAY (2014)
Chagasic megacolon: enteric neurons and related structures
Samir Jabari et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2014)
Secondary Metabolites from Vietnamese Marine Invertebrates with Activity against Trypanosoma brucei and T. cruzi
Nguyen Phuong Thao et al.
MOLECULES (2014)
Next-generation antimalarial from phenotypic screen shows clinical promise
Megan Cully
NATURE REVIEWS DRUG DISCOVERY (2014)
Randomized Trial of Posaconazole and Benznidazole for Chronic Chagas' Disease
Israel Molina et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Characterization of membranolides B-H from Dendrilla membranosa and their activity against leishmaniasis
C Witowski et al.
PLANTA MEDICA (2014)
In vivo imaging of mice infected with bioluminescent Trypanosoma cruzi unveils novel sites of infection
Cristina Henriques et al.
PARASITES & VECTORS (2014)
In vivo imaging of trypanosomes for a better assessment of host-parasite relationships and drug efficacy
S. Goyard et al.
PARASITOLOGY INTERNATIONAL (2014)
Gametocytocidal Screen Identifies Novel Chemical Classes with Plasmodium falciparum Transmission Blocking Activity
Natalie G. Sanders et al.
PLOS ONE (2014)
New drugs with antiprotozoal activity from marine algae: a review
Fabio A. E. Torres et al.
REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY (2014)
Nitro drugs for the treatment of trypanosomatid diseases: past, present, and future prospects
Stephen Patterson et al.
TRENDS IN PARASITOLOGY (2014)
Post kala-azar dermal leishmaniasis: an unresolved mystery
Debanjan Mukhopadhyay et al.
TRENDS IN PARASITOLOGY (2014)
Population Pharmacokinetic Study of Benznidazole in Pediatric Chagas Disease Suggests Efficacy despite Lower Plasma Concentrations than in Adults
Jaime Altcheh et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Trypanosomatids topoisomerase re-visited. New structural findings and role in drug discovery
Rafael Balana-Fouce et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2014)
Target-based vs. phenotypic screenings in Leishmania drug discovery: A marriage of convenience or a dialogue of the deaf?
Rosa M. Reguera et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2014)
Shifting from quinine to artesunate as first-line treatment of severe malaria in children and adults: Saving more lives
Jean Jacques N. Noubiap
JOURNAL OF INFECTION AND PUBLIC HEALTH (2014)
Donor-Derived Trypanosoma cruzi Infection in Solid Organ Recipients in the United States, 2001-2011
S. Huprikar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Benznidazole-Related Adverse Drug Reactions and Their Relationship to Serum Drug Concentrations in Patients with Chronic Chagas Disease
Maria-Jesus Pinazo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Identification of MMV Malaria Box Inhibitors of Plasmodium falciparum Early-Stage Gametocytes Using a Luciferase-Based High-Throughput Assay
Leonardo Lucantoni et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
A Microscale Human Liver Platform that Supports the Hepatic Stages of Plasmodium falciparum and vivax
Sandra March et al.
CELL HOST & MICROBE (2013)
Recent developments in the antiprotozoal and anticancer activities of the 2-alkynoic fatty acids
Nestor M. Carballeira
CHEMISTRY AND PHYSICS OF LIPIDS (2013)
Phenotypic vs. Target-Based Drug Discovery for First-in-Class Medicines
D. C. Swinney
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Toxicokinetic and mechanistic basis for the safety and tolerability of liposomal amphotericin B
Angela S. Loo et al.
EXPERT OPINION ON DRUG SAFETY (2013)
Leishmaniasis: an update of current pharmacotherapy
Shyam Sundar et al.
EXPERT OPINION ON PHARMACOTHERAPY (2013)
Immunomodulatory effects of antileishmanial drugs
Moumita Ghosh et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
A Plasmodium falciparum screening assay for anti-gametocyte drugs based on parasite lactate dehydrogenase detection
Sarah D'Alessandro et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Drug Discovery for Neglected Diseases: Molecular Target-Based and Phenotypic Approaches
Ian H. Gilbert
JOURNAL OF MEDICINAL CHEMISTRY (2013)
A quantitative high throughput assay for identifying gametocytocidal compounds
Takeshi Q. Tanaka et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2013)
Folate metabolism in human malaria parasites-75 years on
Ingrid B. Mueller et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2013)
Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness)
Peter G. E. Kennedy
LANCET NEUROLOGY (2013)
Evaluation of bioluminescence-based assays of anti-malarial drug activity
Sandra Hasenkamp et al.
MALARIA JOURNAL (2013)
Synthesis of Marine α-Methoxylated Fatty Acid Analogs that Effectively Inhibit the Topoisomerase IB from Leishmania donovani with a Mechanism Different from that of Camptothecin
Nestor M. Carballeira et al.
MARINE DRUGS (2013)
Eleganolone, a Diterpene from the French Marine Alga Bifurcaria bifurcata Inhibits Growth of the Human Pathogens Trypanosoma brucei and Plasmodium falciparum
Jean-Baptiste Galle et al.
MARINE DRUGS (2013)
Matching the power of high throughput screening to the chemical diversity of natural products
Curtis J. Henrich et al.
NATURAL PRODUCT REPORTS (2013)
Malaria biology and disease pathogenesis: insights for new treatments
Louis H. Miller et al.
NATURE MEDICINE (2013)
TECHNIQUES & APPLICATIONS A new tool for liver-stage malaria
Christina Tobin Kahrstroem
NATURE REVIEWS MICROBIOLOGY (2013)
Stage-Regulated GFP Expression in Trypanosoma cruzi: Applications from Host-Parasite Interactions to Drug Screening
Rafael Luis Kessler et al.
PLOS ONE (2013)
Aquaporin 2 Mutations in Trypanosoma brucei gambiense Field Isolates Correlate with Decreased Susceptibility to Pentamidine and Melarsoprol
Fabrice E. Graf et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
Chemotherapy for second-stage Human African trypanosomiasis
Vittoria Lutje et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)
Flow cytometric enumeration of Plasmodium berghei-infected red blood cells stained with SYBR Green I
Voravuth Somsak et al.
ACTA TROPICA (2012)
Indotecan (LMP400) and AM13-55: Two Novel Indenoisoquinolines Show Potential for Treating Visceral Leishmaniasis
Rafael Balana-Fouce et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
In Vitro Activity of Fluorescent Dyes against Asexual Blood Stages of Plasmodium falciparum
Fanny Joanny et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Validating a Firefly Luciferase-Based High-Throughput Screening Assay for Antimalarial Drug Discovery
Pulin Che et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2012)
2-Alkynoic fatty acids inhibit topoisomerase IB from Leishmania donovani
Nestor M. Carballeira et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
High content live cell imaging for the discovery of new antimalarial marine natural products
Serena Cervantes et al.
BMC INFECTIOUS DISEASES (2012)
Global Phenotypic Screening for Antimalarials
W. Armand Guiguemde et al.
CHEMISTRY & BIOLOGY (2012)
Whole-cell in vitro screening for gametocytocidal compounds
Leonardo Lucantoni et al.
FUTURE MEDICINAL CHEMISTRY (2012)
Chronic Chagas' heart disease: a disease on its way to becoming a worldwide health problem: epidemiology, etiopathology, treatment, pathogenesis and laboratory medicine
Silvia Gilka Munoz-Saravia et al.
HEART FAILURE REVIEWS (2012)
Visceral Leishmaniasis
Johan van Griensven et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2012)
Adaptation of High-Throughput Screening in Drug Discovery-Toxicological Screening Tests
Pawel Szymanski et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis
Thomas P. C. Dorlo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Drug Screen Targeted at Plasmodium Liver Stages Identifies a Potent Multistage Antimalarial Drug
Filipa P. da Cruz et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Discovery of a Novel Class of Orally Active Trypanocidal N-Myristoyltransferase Inhibitors
Stephen Brand et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma
Peter D. Senter et al.
NATURE BIOTECHNOLOGY (2012)
Leishmaniasis Worldwide and Global Estimates of Its Incidence
Jorge Alvar et al.
PLOS ONE (2012)
Dolabelladienetriol, a Compound from Dictyota pfaffii Algae, Inhibits the Infection by Leishmania amazonensis
Deivid Costa Soares et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Untreated Human Infections by Trypanosoma brucei gambiense Are Not 100% Fatal
Vincent Jamonneau et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Recent developments in sterol 14-demethylase inhibitors for Chagas disease
Frederick S. Buckner et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2012)
Visceral leishmaniasis treatment: What do we have, what do we need and how to deliver it?
Lucio H. Freitas-Junior et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2012)
Antitrypanosomal Activity of Fexinidazole, a New Oral Nitroimidazole Drug Candidate for Treatment of Sleeping Sickness
Marcel Kaiser et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Quantitative proteome profiling informs on phenotypic traits that adapt Leishmania donovani for axenic and intracellular proliferation
Pascale Pescher et al.
CELLULAR MICROBIOLOGY (2011)
First total synthesis and antileishmanial activity of (Z)-16-methyl-11-heptadecenoic acid, a new marine fatty acid from the sponge Dragmaxia undata
Nestor M. Carballeira et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2011)
Identification of Inhibitors of the Leishmania cdc2-Related Protein Kinase CRK3
Laura A. T. Cleghorn et al.
CHEMMEDCHEM (2011)
Trypanocidal Activity of Nitroaromatic Prodrugs: Current Treatments and Future Perspectives
Shane R. Wilkinson et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2011)
Folate metabolic pathways in Leishmania
Tim J. Vickers et al.
ESSAYS IN BIOCHEMISTRY: MOLECULAR PARASITOLOGY (2011)
Fucoidan cures infection with both antimony-susceptible and -resistant strains of Leishmania donovani through Th1 response and macrophage-derived oxidants
Susanta Kar et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
A High-Throughput Screen Targeting Malaria Transmission Stages Opens New Avenues for Drug Development
Kathrin Buchholz et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration
Carrie A. Morris et al.
MALARIA JOURNAL (2011)
4-Acetoxydolastane Diterpene from the Brazilian Brown Alga Canistrocarpus cervicornis as Antileishmanial Agent
Adriana Oliveira dos Santos et al.
MARINE DRUGS (2011)
Kinase Inhibitors from Marine Sponges
Danielle Skropeta et al.
MARINE DRUGS (2011)
Anti-malarial, anti-algal, anti-tubercular, anti-bacterial, anti-photosynthetic, and anti-fouling activity of diterpene and diterpene isonitriles from the tropical marine sponge Cymbastela hooperi
Anthony D. Wright et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2011)
Antileishmanial Sesquiterpenes from the Brazilian Red Alga Laurencia dendroidea
Fernanda Lacerda da Silva Machado et al.
PLANTA MEDICA (2011)
Identification of Small Molecule Lead Compounds for Visceral Leishmaniasis Using a Novel Ex Vivo Splenic Explant Model System
Yaneth Osorio et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
Noninvasive biophotonic imaging for studies of infectious disease
Nuria Andreu et al.
FEMS MICROBIOLOGY REVIEWS (2011)
Discovery of Potent Small-Molecule Inhibitors of Multidrug-Resistant Plasmodium falciparum Using a Novel Miniaturized High-Throughput Luciferase-Based Assay
Edinson Lucumi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
2-Hexadecynoic acid inhibits plasmodial FAS-II enzymes and arrests erythrocytic and liver stage Plasmodium infections
Deniz Tasdemir et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Clinical aspects of hemolysis in patients with P-vivax malaria treated with primaquine, in the Brazilian Amazon
Wilson M. Ramos Junior et al.
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES (2010)
Antiprotozoal Steroidal Saponins from the Marine Sponge Pandaros acanthifolium
Erik L. Regalado et al.
JOURNAL OF NATURAL PRODUCTS (2010)
Effect of Elatol, Isolated from Red Seaweed Laurencia dendroidea, on Leishmania amazonensis
Adriana Oliveira dos Santos et al.
MARINE DRUGS (2010)
Inhibitory Activity of Marine Sponge-Derived Natural Products against Parasitic Protozoa
Ilkay Orhan et al.
MARINE DRUGS (2010)
Single-Dose Liposomal Amphotericin B for Visceral Leishmaniasis in India
Shyam Sundar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Chemotherapy against human African trypanosomiasis: Is there a road to success?
Christian Burri
PARASITOLOGY (2010)
Establishment of an In Vitro Assay for Assessing the Effects of Drugs on the Liver Stages of Plasmodium vivax Malaria
Rana Chattopadhyay et al.
PLOS ONE (2010)
The first total synthesis of the (±)-17-methyl-trans-4,5-methyleneoctadecanoic acid and related analogs with antileishmanial activity
Nestor M. Carballeira et al.
TETRAHEDRON LETTERS (2010)
Antimony Toxicity
Shyam Sundar et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2010)
NECT Is Next: Implementing the New Drug Combination Therapy for Trypanosoma brucei gambiense Sleeping Sickness
Oliver Yun et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
Assessment of Malaria In Vitro Drug Combination Screening and Mixed-Strain Infections Using the Malaria Sybr Green I-Based Fluorescence Assay
Edgie-Mark A. Co et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
High-content live cell imaging with RNA probes: advancements in high-throughput antimalarial drug discovery
Serena Cervantes et al.
BMC CELL BIOLOGY (2009)
Transgenic Leishmania donovani clinical isolates expressing green fluorescent protein constitutively for rapid and reliable ex vivo drug screening
Nasib Singh et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial
Gerardo Priotto et al.
LANCET (2009)
Dissecting the essentiality of the bifunctional trypanothione synthetase-amidase in Trypanosoma brucei using chemical and genetic methods
Susan Wyllie et al.
MOLECULAR MICROBIOLOGY (2009)
Pentavalent Antimonials: New Perspectives for Old Drugs
Frederic Frezard et al.
MOLECULES (2009)
Total Synthesis and Antileishmanial Activity of the Natural Occurring Acetylenic Fatty Acids 6-Heptadecynoic Acid and 6-Icosynoic Acid
Nestor M. Carballeira et al.
LIPIDS (2009)
A comparative study of a flow-cytometry-based assessment of in vitro Plasmodium falciparum drug sensitivity
Stephan Karl et al.
MALARIA JOURNAL (2009)
Pharmacokinetic and Toxicological Profile of Artemisinin Compounds: An Update
Bikash Medhi et al.
PHARMACOLOGY (2009)
Imaging Leishmania development in their host cells
Thierry Lang et al.
TRENDS IN PARASITOLOGY (2009)
Reporter genes facilitating discovery of drugs targeting protozoan parasites
Anuradha Dube et al.
TRENDS IN PARASITOLOGY (2009)
Murine Models for Trypanosoma brucei gambiense Disease Progression-From Silent to Chronic Infections and Early Brain Tropism
Christiane Giroud et al.
PLOS NEGLECTED TROPICAL DISEASES (2009)
Artemisinin-based combination therapy for treating uncomplicated malaria
David Sinclair et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2009)
Plasmodium falciparum:: Development of a transgenic line for screening antimalarials using firefly luciferase as the reporter
Long Cui et al.
EXPERIMENTAL PARASITOLOGY (2008)
Kinetic studies and bioactivity of potential manzamine prodrugs
Abbas Gholipour Shilabin et al.
JOURNAL OF NATURAL PRODUCTS (2008)
Chemical and genetic validation of dihydrofolate reductase-thymidylate synthase as a drug target in African trypanosomes
Natasha Sienkiewicz et al.
MOLECULAR MICROBIOLOGY (2008)
Antiprotozoan activity of Brazilian marine cnidarian extracts and of a modified steroid from the octocoral Carijoa riisei
Juliana Quero Reimao et al.
PARASITOLOGY RESEARCH (2008)
A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes
Shane R. Wilkinson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Performance and reliability of the SYBR Green I based assay for the routine monitoring or susceptibility of Plasmodium falciparum clinical associates
Marie Ange Rason et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2008)
The Natural Progression of Gambiense Sleeping Sickness: What Is the Evidence?
Francesco Checchi et al.
PLOS NEGLECTED TROPICAL DISEASES (2008)
Macrophage and T-Cell Gene Expression in a Model of Early Infection with the Protozoan Leishmania chagasi
Nicholas A. Ettinger et al.
PLOS NEGLECTED TROPICAL DISEASES (2008)
Human African trypanosomiasis: pharmacological re-engagement with a neglected disease
M. P. Barrett et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Target assessment for antiparasitic drug discovery
Julie A. Frearson et al.
TRENDS IN PARASITOLOGY (2007)
Treatment of Kala-Azar in southern Sudan using a 17-day regimen of sodium stibogluconate combined with paromomycin: A retrospective comparison with 30-day sodium stibogluconate monotherapy
Yosef Melaku et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2007)
Injectable paromomycin for visceral leishmaniasis in India
Shyam Sundar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites
Mallika Imwong et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Safety and toxicity of sulfadoxine/pyrimethamine - Implications for malaria prevention in pregnancy using intermittent preventive treatment
Philip J. Peters et al.
DRUG SAFETY (2007)
Cutaneous leishmaniasis
Richard Reithinger et al.
LANCET INFECTIOUS DISEASES (2007)
S-adenosylmethionine in protozoan parasites: Functions, synthesis and regulation
Rosa M. Reguera et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2007)
Targeting atypical trypanosomatid DNA topoisomerase I
Rafael Balana-Fouce et al.
DRUG DISCOVERY TODAY (2006)
Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis)
Jose A. Castro et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2006)
Antimalarial potential of xestoquinone, a protein kinase inhibitor isolated from a Vanuatu marine sponge Xestospongia sp.
Dominique Laurent et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Regulation of ornithine decarboxylase
Anthony E. Pegg
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
New approach for high-throughput screening of drug activity on Plasmodium liver stages
A Gego et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
DNA binding properties of 9-substituted harmine derivatives
RH Cao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Use of Leishmania donovani field isolates expressing the luciferase reporter gene in in vitro drug screening
Ashutosh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
High-throughput screening for potent and selective inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase
J Baldwin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Effectiveness of a 10-day melarsoprol schedule for the treatment of late-stage human African trypanosomiasis: Confirmation from a multinational study (IMPAMEL II)
C Schmid et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Targeting the hemozoin synthesis pathway for new antimalarial drug discovery:: Technologies for in vitro β-hematin formation assay
BL Tekwani et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2005)
Possible mechanism of miltefosine-mediated death of Leishmania donovani
NK Verma et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
RNA interference of Trypanosoma brucei topoisomerase IB:: both subunits are essential
RP Bakshi et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2004)
New manzamine alkaloids from an indo-pacific sponge. Pharmacokinetics, oral availability, and the significant activity of several manzamines against HIV-I, AIDS opportunistic infections, and inflammatory diseases
M Yousaf et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Novel, rapid, and inexpensive cell-based quantification of antimalarial drug efficacy
TN Bennett et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Comparison of noninvasive fluorescent and bioluminescent small animal optical imaging
G Choy et al.
BIOTECHNIQUES (2003)
Mechanisms of arsenical and diamidine uptake and resistance in Trypanosoma brucei
E Matovu et al.
EUKARYOTIC CELL (2003)
Eflornithine for the treatment of human African trypanosomiasis
C Burri et al.
PARASITOLOGY RESEARCH (2003)
Turnover of trypanosomal ornithine decarboxylases
L Persson et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2003)
Myristoyl-CoA:protein N-myristoyltransferase, an essential enzyme and potential drug target in kinetoplastid parasites
HP Price et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Post-kala-azar dermal leishmaniasis
EE Zijistra et al.
LANCET INFECTIOUS DISEASES (2003)
Neuro-inflammatory risk factors for treatment failure in early second stage sleeping sickness patients treated with Pentamidine
V Lejon et al.
JOURNAL OF NEUROIMMUNOLOGY (2003)
Artemisinin: mechanisms of action, resistance and toxicity
SR Meshnick
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2002)
Evidence for a non-LDL-mediated entry route for the trypanocidal drug suramin in Trypanosoma brucei
A Pal et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2002)
Amphotericin B nephrotoxicity
G Deray
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Polyamine Metabolism as Chemotherapeutic Target in Protozoan Parasites
C. J. Bacchi et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2002)
Clinical description of encephalopathic syndromes and risk factors for their occurrence and outcome during melarsoprol treatment of human African trypanosomiasis
J Blum et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2001)
Marine organisms as a source of new anticancer agents
Gilberto Schwartsmann et al.
LANCET ONCOLOGY (2001)
Inhibition of heme detoxification processes underlies the antimalarial activity of terpene isonitrile compounds from marine sponges
AD Wright et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Novel intracellular SbV reducing activity correlates with antimony susceptibility in Leishmania donovani
P Shaked-Mishan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Episomal and stable expression of the luciferase reporter gene for quantifying Leishmania spp. infections in macrophages and in animal models
G Roy et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2000)
In vivo antimalarial activity of the beta-carboline alkaloid manzamine A
KKH Ang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Targeted integration into a rRNA locus results in uniform and high level expression of transgenes in Leishmania amastigotes
A Misslitz et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2000)
Share Paper
